Literature DB >> 29374391

Extracellular Vesicles As miRNA Nano-Shuttles: Dual Role in Tumor Progression.

Marzia Pucci1,2,3, Pablo Reclusa Asiáin1,2, Elena Duréndez Sáez1,4,5, Eloisa Jantus-Lewintre4,5,6, Mahafarin Malarani1,2, Shahanavaj Khan7,8, Simona Fontana3, Aung Naing9, Francesco Passiglia2, Luis E Raez10, Christian Rolfo11,12, Simona Taverna13,14.   

Abstract

Tumor-derived extracellular vesicles (EVs) have a pleiotropic role in cancer, interacting with target cells of the tumor microenvironment, such as fibroblasts, immune and endothelial cells. EVs can modulate tumor progression, angiogenic switch, metastasis, and immune escape. These vesicles are nano-shuttles containing a wide spectrum of miRNAs that contribute to tumor progression. MiRNAs contained in extracellular vesicles (EV-miRNAs) are disseminated in the extracellular space and are able to influence the expression of target genes with either tumor suppressor or oncogenic functions, depending on both parental and target cells. Metastatic cancer cells can balance their oncogenic potential by expressing miRNAs with oncogenic function, whilst exporting miRNAs with tumor suppressor roles out of the cells. Importantly, treatment of cancer cells with specific natural and chemical compounds could induce the elimination of miRNAs with oncogenic function, thereby reducing their aggressiveness. In this review, we discuss the mechanisms by which EV-miRNAs, acting as miRNAs with oncogenic or tumor suppressor functions, could contribute to cancer progression.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29374391     DOI: 10.1007/s11523-018-0551-8

Source DB:  PubMed          Journal:  Target Oncol        ISSN: 1776-2596            Impact factor:   4.493


  108 in total

1.  The RNA-Binding Protein SYNCRIP Is a Component of the Hepatocyte Exosomal Machinery Controlling MicroRNA Sorting.

Authors:  Laura Santangelo; Giorgio Giurato; Carla Cicchini; Claudia Montaldo; Carmine Mancone; Roberta Tarallo; Cecilia Battistelli; Tonino Alonzi; Alessandro Weisz; Marco Tripodi
Journal:  Cell Rep       Date:  2016-10-11       Impact factor: 9.423

2.  Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes).

Authors:  R M Johnstone; M Adam; J R Hammond; L Orr; C Turbide
Journal:  J Biol Chem       Date:  1987-07-05       Impact factor: 5.157

3.  Exosomal miR-34s panel as potential novel diagnostic and prognostic biomarker in patients with hepatoblastoma.

Authors:  Chenwei Jiao; Xiaohu Jiao; Anzhi Zhu; Juntao Ge; Xiaoqing Xu
Journal:  J Pediatr Surg       Date:  2016-10-14       Impact factor: 2.545

4.  Role of anti-oncomirs miR-143 and -145 in human colorectal tumors.

Authors:  Y Akao; Y Nakagawa; I Hirata; A Iio; T Itoh; K Kojima; R Nakashima; Y Kitade; T Naoe
Journal:  Cancer Gene Ther       Date:  2010-01-22       Impact factor: 5.987

Review 5.  Contribution of proteomics to understanding the role of tumor-derived exosomes in cancer progression: state of the art and new perspectives.

Authors:  Simona Fontana; Fontana Simona; Laura Saieva; Saieva Laura; Simona Taverna; Taverna Simona; Riccardo Alessandro; Alessandro Riccardo
Journal:  Proteomics       Date:  2013-03-22       Impact factor: 3.984

6.  Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis.

Authors:  Weiying Zhou; Miranda Y Fong; Yongfen Min; George Somlo; Liang Liu; Melanie R Palomares; Yang Yu; Amy Chow; Sean Timothy Francis O'Connor; Andrew R Chin; Yun Yen; Yafan Wang; Eric G Marcusson; Peiguo Chu; Jun Wu; Xiwei Wu; Arthur Xuejun Li; Zhuo Li; Hanlin Gao; Xiubao Ren; Mark P Boldin; Pengnian Charles Lin; Shizhen Emily Wang
Journal:  Cancer Cell       Date:  2014-04-14       Impact factor: 31.743

7.  Identifying mRNA, microRNA and protein profiles of melanoma exosomes.

Authors:  Deyi Xiao; Joanna Ohlendorf; Yinlu Chen; Douglas D Taylor; Shesh N Rai; Sabine Waigel; Wolfgang Zacharias; Hongying Hao; Kelly M McMasters
Journal:  PLoS One       Date:  2012-10-09       Impact factor: 3.240

8.  EVpedia: an integrated database of high-throughput data for systemic analyses of extracellular vesicles.

Authors:  Dae-Kyum Kim; Byeongsoo Kang; Oh Youn Kim; Dong-Sic Choi; Jaewook Lee; Sae Rom Kim; Gyeongyun Go; Yae Jin Yoon; Ji Hyun Kim; Su Chul Jang; Kyong-Su Park; Eun-Jeong Choi; Kwang Pyo Kim; Dominic M Desiderio; Yoon-Keun Kim; Jan Lötvall; Daehee Hwang; Yong Song Gho
Journal:  J Extracell Vesicles       Date:  2013-03-19

9.  Clinical significance of plasmacytoid dendritic cells and myeloid-derived suppressor cells in melanoma.

Authors:  Ines Chevolet; Reinhart Speeckaert; Max Schreuer; Bart Neyns; Olga Krysko; Claus Bachert; Mireille Van Gele; Nanja van Geel; Lieve Brochez
Journal:  J Transl Med       Date:  2015-01-16       Impact factor: 5.531

Review 10.  Exosome: emerging biomarker in breast cancer.

Authors:  Yunlu Jia; Yongxia Chen; Qinchuan Wang; Ushani Jayasinghe; Xiao Luo; Qun Wei; Ji Wang; Hanchu Xiong; Cong Chen; Bin Xu; Wenxian Hu; Linbo Wang; Wenhe Zhao; Jichun Zhou
Journal:  Oncotarget       Date:  2017-06-20
View more
  14 in total

Review 1.  Clinical relevance of circulating molecules in cancer: focus on gastrointestinal stromal tumors.

Authors:  Gloria Ravegnini; Giulia Sammarini; César Serrano; Margherita Nannini; Maria A Pantaleo; Patrizia Hrelia; Sabrina Angelini
Journal:  Ther Adv Med Oncol       Date:  2019-03-01       Impact factor: 8.168

Review 2.  Surveillance of Tumour Development: The Relationship Between Tumour-Associated RNAs and Ribonucleases.

Authors:  Nadezhda Mironova; Valentin Vlassov
Journal:  Front Pharmacol       Date:  2019-09-13       Impact factor: 5.810

Review 3.  Breast Cancer Derived Extracellular Vesicles in Bone Metastasis Induction and Their Clinical Implications as Biomarkers.

Authors:  Simona Taverna; Ilaria Giusti; Sandra D'Ascenzo; Laura Pizzorno; Vincenza Dolo
Journal:  Int J Mol Sci       Date:  2020-05-18       Impact factor: 5.923

4.  Can Be miR-126-3p a Biomarker of Premature Aging? An Ex Vivo and In Vitro Study in Fabry Disease.

Authors:  Alessia Lo Curto; Simona Taverna; Maria Assunta Costa; Rosa Passantino; Giuseppa Augello; Giorgia Adamo; Anna Aiello; Paolo Colomba; Carmela Zizzo; Marco Zora; Giulia Accardi; Giuseppina Candore; Daniele Francofonte; Tiziana Di Chiara; Riccardo Alessandro; Calogero Caruso; Giovanni Duro; Giuseppe Cammarata
Journal:  Cells       Date:  2021-02-09       Impact factor: 6.600

Review 5.  Circular RNA in colorectal cancer.

Authors:  Anthony Li; Wei Cen Wang; Vivian McAlister; Qinfeng Zhou; Xiufen Zheng
Journal:  J Cell Mol Med       Date:  2021-03-09       Impact factor: 5.310

6.  Hsa-miR-335 enhances cell migration and invasion in lung adenocarcinoma through targeting Copine-1.

Authors:  Yang Wang; Jing Zhang; Li-Ye Zhong; Shang-Jia Huang; Nan-Nan Yu; Lan Ouyang; Yu-Long Niu; Jun-Xiong Chen; Chun-Hua Lu; Qing-Yu He
Journal:  MedComm (2020)       Date:  2021-11-04

7.  P2X7 promotes metastatic spreading and triggers release of miRNA-containing exosomes and microvesicles from melanoma cells.

Authors:  Anna Pegoraro; Elena De Marchi; Manuela Ferracin; Elisa Orioli; Michele Zanoni; Cristian Bassi; Anna Tesei; Marina Capece; Emi Dika; Massimo Negrini; Francesco Di Virgilio; Elena Adinolfi
Journal:  Cell Death Dis       Date:  2021-11-16       Impact factor: 8.469

8.  Extracellular Vesicle-derived circular RNAs confers chemoresistance in Colorectal cancer.

Authors:  Kha Wai Hon; Nurul Syakima Ab-Mutalib; Nik Muhd Aslan Abdullah; Rahman Jamal; Nadiah Abu
Journal:  Sci Rep       Date:  2019-11-11       Impact factor: 4.379

Review 9.  Exosomal microRNAs in non-small cell lung cancer.

Authors:  Elena Duréndez-Sáez; Susana Torres-Martinez; Silvia Calabuig-Fariñas; Marina Meri-Abad; Macarena Ferrero-Gimeno; Carlos Camps
Journal:  Transl Cancer Res       Date:  2021-06       Impact factor: 1.241

Review 10.  Shaping Immune Responses in the Tumor Microenvironment of Ovarian Cancer.

Authors:  Xin Luo; Jing Xu; Jianhua Yu; Ping Yi
Journal:  Front Immunol       Date:  2021-06-23       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.